a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders
Industry PharmaceuticalsMajor
A.I.dvisor tells us that BIIB and OGN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIIB and OGN's prices will move in lockstep.
Ticker / NAME | Correlation To BIIB | 1D Price Change % | ||
---|---|---|---|---|
BIIB | 100% | -1.48% | ||
OGN - BIIB | 33% Poorly correlated | +0.19% | ||
NVS - BIIB | 31% Poorly correlated | -1.01% | ||
PFE - BIIB | 31% Poorly correlated | +2.02% | ||
AZN - BIIB | 28% Poorly correlated | +0.15% | ||
JNJ - BIIB | 24% Poorly correlated | +0.39% | ||
More |
Ticker / NAME | Correlation To BIIB | 1D Price Change % |
---|---|---|
BIIB | 100% | -1.48% |
autoimmune theme (3 stocks) | 98% Closely correlated | -2.17% |
neurological theme (10 stocks) | 57% Loosely correlated | +1.78% |
diseases theme (41 stocks) | 57% Loosely correlated | -1.18% |
therapy theme (23 stocks) | 54% Loosely correlated | -3.41% |
drugs theme (254 stocks) | 52% Loosely correlated | -1.72% |
More |